These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 339619)

  • 21. Introduction of a mini-gene encoding a five-amino acid peptide confers erythromycin resistance on Bacillus subtilis and provides temporary erythromycin protection in Proteus mirabilis.
    Novikova SI; Bushueva AM; Trachuk LA; Konstantinova GE; Serkina AV; Hoischen C; Gumpert J; Chestukhina GG; Mankin A; Shevelev AB
    FEMS Microbiol Lett; 2000 Jan; 182(2):213-8. PubMed ID: 10620668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Emerging bacterial pathogens: Escherichia coli, Enterobacter aerogenes and Proteus mirabilis clinical isolates harbouring the same transferable plasmid coding for metallo-beta-lactamase VIM-1 in Greece.
    Galani I; Souli M; Koratzanis E; Koratzanis G; Chryssouli Z; Giamarellou H
    J Antimicrob Chemother; 2007 Mar; 59(3):578-9. PubMed ID: 17255145
    [No Abstract]   [Full Text] [Related]  

  • 23. Identification and characterization of new members of the SXT/R391 family of integrative and conjugative elements (ICEs) in Proteus mirabilis.
    Bie L; Wu H; Wang XH; Wang M; Xu H
    Int J Antimicrob Agents; 2017 Aug; 50(2):242-246. PubMed ID: 28602701
    [TBL] [Abstract][Full Text] [Related]  

  • 24. R plasmids coding for gentamicin, tobramycin, and carbenicillin resistance in Serratia, Klebsiella and Escherichia coli strains from a single clinical source.
    Knothe H; Kettner M; Kopsová D; Krcméry V
    Chemotherapy; 1977; 23(1):37-43. PubMed ID: 401718
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased mutability to fosfomycin resistance in Proteus mirabilis clinical isolates.
    Fonseca MRB; Sato JL; Lima-Noronha MA; Migliorini LB; Fernández-Silva FS; Galhardo RS
    Infect Genet Evol; 2018 Mar; 58():27-33. PubMed ID: 29248795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Genetic control of antibiotic resistance and the R plasmid properties of clinical E. coli strains].
    Vakulenko SB; Bodunkova LE; Fomina IP; Navashin SM
    Zh Mikrobiol Epidemiol Immunobiol; 1982 Sep; (9):45-9. PubMed ID: 6755985
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transmissible drug resistance in Proteus mirabilis.
    Rao RS; Sundaraj T; Subramanian S
    Indian J Pathol Microbiol; 1984 Jan; 27(1):37-42. PubMed ID: 6392091
    [No Abstract]   [Full Text] [Related]  

  • 28. Chromosome transfer and R-prime formation by an RP4::mini-Mu derivative in Escherichia coli, Salmonella typhimurium, Klebsiella pneumoniae, and Proteus mirabilis.
    Van Gijsegem F; Toussaint A
    Plasmid; 1982 Jan; 7(1):30-44. PubMed ID: 6211681
    [No Abstract]   [Full Text] [Related]  

  • 29. Transition of the R factor NR1 and Proteus mirabilis: level of drug resistance of nontransitioned and transitioned cells.
    Hashimoto H; Rownd RH
    J Bacteriol; 1975 Jul; 123(1):56-68. PubMed ID: 1095563
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Spread and transfer of plasmid resistance in Escherichia coli].
    Rudneva SN; Stoliarova LG; Ershov AA; Pantiukhova VV
    Antibiotiki; 1980 Jun; 25(6):429-32. PubMed ID: 6994630
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antimicrobial Susceptibility and Molecular Epidemiology of
    Lin MF; Liou ML; Kuo CH; Lin YY; Chen JY; Kuo HY
    Microb Drug Resist; 2019 Nov; 25(9):1338-1346. PubMed ID: 31295061
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proceedings: Inducible tetracycline resistance in R+ and R- strains of Proteus mirabilis.
    Hesslewood SR
    J Pharm Pharmacol; 1975 Dec; 27 Suppl?-2():45P. PubMed ID: 2719
    [No Abstract]   [Full Text] [Related]  

  • 33. Transferable antibiotic resistance in nosocomial Stenotrophomonas maltophilia strain.
    Blahová J; Králiková K; Krcméry V; Torsová V
    Diagn Microbiol Infect Dis; 1997 Nov; 29(3):129-32. PubMed ID: 9401804
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PGI2 Is a Novel SGI1-Relative Multidrug-Resistant Genomic Island Characterized in Proteus mirabilis.
    Lei CW; Chen YP; Kong LH; Zeng JX; Wang YX; Zhang AY; Wang HN
    Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29463532
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association among biofilm formation, virulence gene expression, and antibiotic resistance in Proteus mirabilis isolates from diarrhetic animals in Northeast China.
    Sun Y; Wen S; Zhao L; Xia Q; Pan Y; Liu H; Wei C; Chen H; Ge J; Wang H
    BMC Vet Res; 2020 Jun; 16(1):176. PubMed ID: 32503535
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Envelope alterations produced by R factors in Proteus mirabilis.
    Hesslewood SR; Smith JT
    J Gen Microbiol; 1974 Nov; 85(1):146-52. PubMed ID: 4612103
    [No Abstract]   [Full Text] [Related]  

  • 37. Phenotypic and molecular characterization of antimicrobial resistance in Proteus mirabilis isolates from dogs.
    Harada K; Niina A; Shimizu T; Mukai Y; Kuwajima K; Miyamoto T; Kataoka Y
    J Med Microbiol; 2014 Nov; 63(Pt 11):1561-1567. PubMed ID: 25187600
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of antibiotic resistance patterns in collections of Escherichia coli and Proteus mirabilis uropathogenic strains.
    Adamus-Bialek W; Zajac E; Parniewski P; Kaca W
    Mol Biol Rep; 2013 Apr; 40(4):3429-35. PubMed ID: 23283741
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chromosomal location of the fosA3 and bla
    He D; Liu L; Guo B; Wu S; Chen X; Wang J; Zeng Z; Liu JH
    Int J Antimicrob Agents; 2017 Apr; 49(4):443-448. PubMed ID: 28238801
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gene copy number effects in the mer operon of plasmid NR1.
    Nakahara H; Kinscherf TG; Silver S; Miki T; Easton AM; Rownd RH
    J Bacteriol; 1979 Apr; 138(1):284-7. PubMed ID: 374374
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.